Fundraising FoxPureTech Health — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health.
BiotechDigital HealthHealthtechWellness & FitnessBoston, US
Yishai Zohar(Director, President, and Chief Executive Officer)inElliot Maltz(Treasurer)in
BoardJohn LaMattina(Director)Elon Boms(Director)inMeghan Fitzgerald(Director)Robert Forrester(Director)in
Co-investorsLaunchCapitalSalica InvestmentsCapstar VenturesInvescoOrbiMedVitruvian Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.